Evidence map›Paper›PMID 39439213›Full record

ArticleThe journal of pathology. Clinical research2024

Assessing the impact of deep-learning assistance on the histopathological diagnosis of serous tubal intraepithelial carcinoma (STIC) in fallopian tubes.

Joep Ma Bogaerts, Miranda P Steenbeek, John-Melle Bokhorst, Majke Hd van Bommel, Luca Abete, Francesca Addante, Mariel Brinkhuis, Alicja Chrzan, Fleur Cordier, Mojgan Devouassoux-Shisheboran and 24 more

Abstract readMulticenter Study
In one paragraph

Article in The journal of pathology. Clinical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Joep Ma BogaertsDepartment of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0003-0772-6712
Miranda P SteenbeekDepartment of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands.
John-Melle BokhorstDepartment of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
Majke Hd van BommelDepartment of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands.
Luca AbeteDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Francesca AddantePathology Unit, Department of Woman and Child's Health and Public Health Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Mariel BrinkhuisDepartment of Pathology, LabPON, Hengelo, The Netherlands.
Alicja ChrzanDepartment of Pathology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Fleur CordierDepartment of Pathology, Ghent University Hospital, Ghent, Belgium.ORCID 0000-0003-0876-3398
Mojgan Devouassoux-ShisheboranDepartment of Pathology, Hospices Civils de Lyon, Lyon, France.
Juan Fernández-PérezDepartment of Pathology, University Hospital Virgen de la Arrixaca, Murcia, Spain.
Anna FischerInstitute for Pathology and Neuropathology, University of Tuebingen Medical Center II, Tuebingen, Germany.
C Blake GilksDepartment of Pathology and Laboratory Medicine, University of British Columbia and Vancouver General Hospital, Vancouver, Canada.ORCID 0000-0001-7889-8250
Angela GuerrieroGeneral Pathology and Cytopathology Unit, Department of Medicine-DMED, University of Padua, Padua, Italy.
Marta JaconiDepartment of Pathology, San Gerardo Hospital, Monza, Italy.
Tony G KleijnDepartment of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands.
Loes KooremanDepartment of Pathology, and GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.
Spencer MartinDepartment of Pathology and Laboratory Medicine, University of British Columbia and Vancouver General Hospital, Vancouver, Canada.
Jakob MillaInstitute for Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.
Nadine NarducciPathology Department, Ospedale dell'Angelo, Venezia-Mestre, Italy.
Chara NtalaDepartment of Pathology, St. George's University Hospitals, London, UK.
Vinita ParkashDepartment of Pathology, Yale School of Medicine and Yale School of Public Health, New Haven, CT, USA.
Christophe de PauwDepartment of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
Joseph T RabbanDepartment of Pathology, University of California San Francisco, San Francisco, CA, USA.
Lucia RijstenbergDepartment of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Robert RottschollInstitute for Pathology and Neuropathology, University of Tuebingen Medical Center II, Tuebingen, Germany.
Annette StaeblerInstitute for Pathology and Neuropathology, University of Tuebingen Medical Center II, Tuebingen, Germany.
Koen Van de VijverDepartment of Pathology, Cancer Research Institute Ghent (CRIG), Ghent University Hospital, Ghent, Belgium.ORCID 0000-0002-2026-9790
Gian Franco ZannoniPathology Unit, Department of Woman and Child's Health and Public Health Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Monica van ZantenDepartment of Pathology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
AI‐STIC Study Group
Joanne A de HulluDepartment of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands.
Michiel SimonsDepartment of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
Jeroen Awm van der LaakDepartment of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.

Funding

KWF Kankerbestrijding 12950
6 · The paper itself

Abstract

In recent years, it has become clear that artificial intelligence (AI) models can achieve high accuracy in specific pathology-related tasks. An example is our deep-learning model, designed to automatically detect serous tubal intraepithelial carcinoma (STIC), the precursor lesion to high-grade serous ovarian carcinoma, found in the fallopian tube. However, the standalone performance of a model is insufficient to determine its value in the diagnostic setting. To evaluate the impact of the use of this model on pathologists' performance, we set up a fully crossed multireader, multicase study, in which 26 participants, from 11 countries, reviewed 100 digitalized H&E-stained slides of fallopian tubes (30 cases/70 controls) with and without AI assistance, with a washout period between the sessions. We evaluated the effect of the deep-learning model on accuracy, slide review time and (subjectively perceived) diagnostic certainty, using mixed-models analysis. With AI assistance, we found a significant increase in accuracy (p < 0.01) whereby the average sensitivity increased from 82% to 93%. Further, there was a significant 44 s (32%) reduction in slide review time (p < 0.01). The level of certainty that the participants felt versus their own assessment also significantly increased, by 0.24 on a 10-point scale (p < 0.01). In conclusion, we found that, in a diverse group of pathologists and pathology residents, AI support resulted in a significant improvement in the accuracy of STIC diagnosis and was coupled with a substantial reduction in slide review time. This model has the potential to provide meaningful support to pathologists in the diagnosis of STIC, ultimately streamlining and optimizing the overall diagnostic process.

Indexed as

Carcinoma in SituCystadenocarcinoma, SerousDeep LearningFallopian Tube NeoplasmsFemaleHumansImage Interpretation, Computer-AssistedObserver VariationReproducibility of Resultsartificial intelligencecomputational pathologydeep learninghigh‐grade serous carcinomahistopathologyserous tubal intraepithelial carcinomaSTIC

Identifiers

PMID39439213
PMCPMC11496567

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.